PIRFENIDONE | A212596 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Genentech, Inc. et al v. Aurobindo Pharma Limited et al 16 patentsANDA 212596pirfenidone | D. Del. | 2019-01-17 | Terminated 2021-10-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.24
per ea
Lowest NADAC/Unit
$0.8608
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 59651023990PIRFENIDONE 801 MG TABLET | $2.24 | EA | Generic | — | 2026-06-17 |
| 59651023827PIRFENIDONE 267 MG TABLET | $0.8608 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.